Israel Active

Hailed as a world breakthrough, physicians from Schneider Children's Medical Center in Israel completed a successful trial of the MD-Logic Artificial Pancreas (MDLAP). It offers the potential of a “normal” life for diabetic youngsters by using an automatic insulin delivery system during the night. It thus eliminates the need for regular self-testing of blood glucose levels and insulin injections.

Brainsway’s non-invasive proprietary coil has successfully demonstrated that it can stimulate the motor cortex for the lower limbs in patients with advanced multiple sclerosis.

The International Conference on Medicine and Medical Clowning is taking place currently in Jerusalem. Clown therapy is becoming one of Israel’s most important exports.

The $10m state-of-the-art station includes a modern blood collection centre, auditorium, visitors’ centre, facilities for more than 60 ambulances and mobile intensive care units and those who man them, and an advanced system for locating every building in the city and its environs.

Israel’s Given Imaging makes the world-famous PillCam miniature camera and developed the unique Bravo pH capsule that diagnoses sufferers of Gastroesophageal Reflux Disease. The video celebrates Given Imaging’s 10th anniversary of its NASDAQ listing - an inspiring Israeli success story.

Israel’s Enopace Biomedical is developing a non-invasive implant that prevents heart failure by easing the pressure in the left ventricle and improving blood flow to the heart. It could be the biggest breakthrough treatment for congestive heart failure.

The results of a five-year study shows that Teva’s Copaxone was the best of all current drug treatments for controlling the disease’s adverse impact on patients’ brain volume.

Surgeons at Petah Tikva’s Children’s Medical Centre removed a 3.5 cm screw that had been swallowed by a three-year old boy. Dr Noam Zavit used a tiny “basket” to pick up the screw and pull it out through the oesophagus and throat. In August, Dr Zavit pulled an open safety pin from the throat of an 11-month-old baby.

Tel Aviv University scientist Matti Mintz successfully implanted a robotic cerebellum into the skull of a rodent with brain damage, allowing it to function normally again.

Israeli biotech Prolor reported positive results in animal trials of its haemophilia drug Factor VIIa-CTP.